Advertisement

Primary and Secondary Angle-Closure Glaucomas

  • Marshall N. Cyrlin
Chapter

Abstract

Almost 70 million cases of glaucoma have been diagnosed worldwide, approximately half of which are classified as angle-closure glaucoma (ACG).1 Lowe, in 1955, emphasized the study of the anterior chamber angle facilitating the early classification of angle-closure glaucoma.2 Among patients with angle closure, primary angle-closure glaucoma (PACG) is the most common diagnosis. PACG is more common in Asians than in any other ethnic group.3 PACG, primary open angle glaucoma (POAG), and chronic angle-closure glaucoma (CACG) are collectively a major cause of bilateral blindness worldwide, and responsible for more than 90% of the bilateral blindness in China.4 It is estimated that by the year 2020, there will be approximately 21 million of cases of PACG, with more than 5.3 million bilaterally blind individuals as a result of angle closure.5

Keywords

Trabecular Meshwork Central Retinal Vein Occlusion Angle Closure Anterior Chamber Depth Anterior Chamber Angle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hyams S. Angle-closure glaucoma, a comprehensive review of primary and secondary angle-closure glaucoma. Amsterdam: Kugler & Ghedini; 1990, p 1.Google Scholar
  2. 2.
    Lowe RF. A history of primary angle closure glaucoma. Surv Ophthalmol. 1995;40:163–170.PubMedGoogle Scholar
  3. 3.
    Foster PJ. Epidemiology, classification and mechanism. In: Weinreb, RN, Friedman, DS, eds. Angle closure and angle closure glaucoma. The Hague, The Netherlands: Kuegler; 2006:1–20Google Scholar
  4. 4.
    Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem? Br J Ophthalmol. 2001;85:1277–1282.PubMedGoogle Scholar
  5. 5.
    Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267.PubMedGoogle Scholar
  6. 6.
    Wang N, Li S, Liang Y. Classification. In: Hong C, Yamamoto T, eds. Angle closure glaucoma. Amsterdam, The Netherlands: Kuegler; 2007:41–55.Google Scholar
  7. 7.
    Foster PJ, Buhrman RR, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002;86:238–242.PubMedGoogle Scholar
  8. 8.
    Ritch R, Lowe RF. Angle-Closure Glaucoma - Clinical Types. In: Ritch R, Shields MB, Krupin T, eds. The glaucomas. 2nd ed. St. Louis: Mosby; 1996:801-840.Google Scholar
  9. 9.
    Filho AD, Cronemberger S, Mérula RV, Calixto N. Comparative study between plateau iris configuration and primary open angle glaucoma with narrow angle using ultrasound biomicroscopy. Invest Ophthalmol Vis Sci 2009;43:ARVO E-Abstract 3363Google Scholar
  10. 10.
    Ritch R, Tham CCY, et al. Argon laser peripheral iridoplasty in the management of plateau iris syndrome: long-term follow-up. Ophthalmology. 2004;111:104–108.PubMedGoogle Scholar
  11. 11.
    Ritch R. Laser and medical treatment of primary angle closure glaucoma. In: Weinreb RN, Friedman DS, eds. Angle closure and angle closure glaucoma. The Hague, The Netherlands: Kuegler; 2006:37–54Google Scholar
  12. 12.
    Peng D, Zhang X, Yu K. Argon laser peripheral iridoplasty and laser iridectomy for plateau iris glaucoma. Zhonghua Yan Ke Za Zhi. 1997;33:165–168.PubMedGoogle Scholar
  13. 13.
    Dellaporta A. Historical notes on gonioscopy. Surv Ophthalmol. 1975;20:137–149.PubMedGoogle Scholar
  14. 14.
    Forbes M. Gonioscopy with corneal indentation: a method for distinguishing between appositional closure and synechial closure. Arch Opthalmol. 1966;76:488–497.Google Scholar
  15. 15.
    Friedman DS, Mingguang H. Anterior chamber angle assessment techniques. Surv Ophthalmol. 2008;53:250–273.PubMedGoogle Scholar
  16. 16.
    Ritch R, Liebman J, Tello C. A construct for understanding angle closure glaucoma: the role of ultrasound biomicroscopy. Ophthalmol Clin North Am. 1995;8:281–293.Google Scholar
  17. 17.
    Lieberman J. Ultrasound biomicroscopy. In: Weinreb RN, Friedman DS, eds. Angle closure and angle closure glaucoma. The Hague, The Netherlands: Kuegler; 2006:71Google Scholar
  18. 18.
    Baskaran M. Devices for screening for angle closure. In: Weinreb RN, Friedman DS, eds. Angle closure and angle closure glaucoma. The Hague, The Netherlands: Kuegler; 2006:73–74.Google Scholar
  19. 19.
    Tello C, Rothman R, Ishikawa H, Ritch R. Differential diagnosis of the angle closure glaucomas. Ophthalmol Clin North Am. 2000;13:443–453.Google Scholar
  20. 20.
    Yao B, Wu L, Zhang C, Wang X. Ultrasound biometric features associated with angle closure in fellow eyes of acute primary angle closure after laser iridotomy. Ophthalmology. 2009;116:444–448.PubMedGoogle Scholar
  21. 21.
    Kashiwagi K, Kashiwagi F, Toda Y, et al. A newly developed peripheral anterior chamber depth analysis system: principle, accuracy and reproducibility. Br J Ophthalmol. 2004;88:1036–1041.PubMedGoogle Scholar
  22. 22.
    Asawaphureekorn S. New approaches to visualize the anterior chamber angle. In: Hong C, Yamamoto T, eds. Angle closure glaucoma. Amsterdam, The Netherlands: Kuegler; 2007:101–113.Google Scholar
  23. 23.
    Nolan WP, Foster PJ, Devereux JG, Uranchimeg D, Johnson GJ, Baasanhu J. YAG laser iridotomy treatment for primary angle-closure in east Asian eyes. Br J Ophthalmol. 2000;84:1255–1259.PubMedGoogle Scholar
  24. 24.
    Gazzard G, Friedman DS, Devereux JG, Chew PT, Seah SK. A prospective ultrasound biomicroscopy evaluation of changes in anterior segment morphology after laser iridotomy in Asian eyes. Ophthalmology. 2003;110:630–638.PubMedGoogle Scholar
  25. 25.
    Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110:1484–1490.PubMedGoogle Scholar
  26. 26.
    Shiose Y, Kitazawa Y, Tsukuhara S, et al. Epidermiology of glaucoma in Japan - a nationwide glaucoma survey. Jpn J Ophthalmol. 1991;35:133–153.PubMedGoogle Scholar
  27. 27.
    Foster PJ, Gaasanhu J, Alsbirk PH, Munkhbayar D, Uranchimeg D, Johnson GJ. Glaucoma in Mongolia - a population-based survey in Hövsgöl Province, Northern Mongolia. Arch Ophthalmol. 1996;114:1235–1241.PubMedGoogle Scholar
  28. 28.
    Yamamoto T, Iwase A, Araie M, et al. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. 2005;112:1661–1669.PubMedGoogle Scholar
  29. 29.
    Bourne RRA, Sukudom P, Foster PJ, et al. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok. Br J Ophthalmol. 2003;87:1069–1074.PubMedGoogle Scholar
  30. 30.
    Salmon JF, Mermoud A, Ivey A, Swanevelder SA, Hoffman M. The prevalence of primary angle-closure glaucoma and open angle glaucoma in Mamre, Western Cape, South Africa. Arch Ophthalmol. 1993;111:1263–1269.PubMedGoogle Scholar
  31. 31.
    Seah SKL, Foster PJ, Chew PT, et al. Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. Arch Ophthalmol. 1997;115:1436–1440.PubMedGoogle Scholar
  32. 32.
    Alsbirk PH. Anterior chamber depth in Greenland Eskimos. I. A population study of variation with age and sex. Acta Ophthalmol. 1974;52:551–564.Google Scholar
  33. 33.
    Foster PJ, Alsbirk PH, Baasanhu J, Munkhbayar D, Uranchimeg D, Johnson GJ. Anterior chamber depth in Mogolians. Vatiation with age, sex and method of measurement. Am J Ophthalmol. 1997;124:53–60.PubMedGoogle Scholar
  34. 34.
    Foster PJ, Devereux JG, Alsbirk PH, et al. Detection of gonioscopically occludable angles and primary angle closure glaucoma by estimation of limbal chamber depth in Asians: modified grading scheme. Br J Ophthalmol. 2000;84:186–192.PubMedGoogle Scholar
  35. 35.
    Devereux JG, Foster PJ, Baasanhu J, et al. Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population. Arch Ophthalmol. 2000;118:257–263.PubMedGoogle Scholar
  36. 36.
    Chang BM, Liebman JM, Ritch R. Angle closure in younger patients. Trans Am Ophthalmol Soc. 2002;100:201–214.PubMedGoogle Scholar
  37. 37.
    Angle Closure Glaucoma. Coffi, G.A., Durcan, F.J. Girkin, C. A. et al  Chapter 5 in Section 10 of Basic and Clinical Science Course 2008-2009. publisher American Academy of Ophthalmology; 2008; 5:126–128.
  38. 38.
    Van Rens GH, Arkell SM, Charlton W, Doesburg W. Primary angle-closure glaucoma among Alaskan Eskimos. Doc Ophthalmol. 1988;70:265–276.PubMedGoogle Scholar
  39. 39.
    Arkell SM, Lightman DA, Sommer A, et al. The prevalence of glaucoma among Eskimos of northwest Alaska. Arch Ophthalmol. 1987;105:482–485.PubMedGoogle Scholar
  40. 40.
    Bourne RR, Sorensen KE, Klauber A, et al. Glaucoma in east greenlandic inuit - a population survey in Ittoqqortoonmiit (Scoresbysund). Acta Ophthalmol Scand. 2001;79:462–467.PubMedGoogle Scholar
  41. 41.
    Congdon NG, Quigley HA, Hung PT, et al. Screening techniques for angle-closure glaucoma in rural Taiwan. Acta Ophthalmol Scand. 1996;74:113–119.PubMedGoogle Scholar
  42. 42.
    Foster PJ, Baasanhu J, Alsbirk PH, et al. Glaucoma in Mongolia. Apopulation-based survey in Hovsgol province, northern Mongolia. Arch Ophthalmol 1996;114:1235–1241PubMedGoogle Scholar
  43. 43.
    Sim DH, Goh LG, Ho T. Glaucoma pattern amongst the elderly Chinese in Singapore. Ann Acad Med Singapore. 1998;27(6):819–823.PubMedGoogle Scholar
  44. 44.
    Dandona L, Dandona R, Mandal P, et al. Angle-closure glaucoma in an urban population in southern India: the Andhra Pradesh Eye Disease Study. Ophthalmology. 2000;107:1710–1716.PubMedGoogle Scholar
  45. 45.
    Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic Subjects: Proyecto VER. Arch Ophthalmol 2001;119(12):1819–1826.PubMedGoogle Scholar
  46. 46.
    Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991;134:1102–1110.PubMedGoogle Scholar
  47. 47.
    Buhrmann RR, Quigley HA, Barron Y, et al. Prevalence of glaucoma in a rural East African population. Invest Ophthalmol Vis Sci 2000;41:40–48.PubMedGoogle Scholar
  48. 48.
    Rotchford AP, Johnson GJ. Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Arch Ophthalmol. 2002;120:471–478.PubMedGoogle Scholar
  49. 49.
    Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology. 1998;105:209–215.PubMedGoogle Scholar
  50. 50.
    Bankes JL, Perkins ES, Tsolakis S, Wright JE. Bedford glaucoma survey. Br Med J. 1968;1:791–796.PubMedGoogle Scholar
  51. 51.
    Bengtsson B. The prevalence of glaucoma. Br J Ophthalmol 1981;65:46–49.PubMedGoogle Scholar
  52. 52.
    Hollows FC, Graham PA. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 1966;50:570–586.PubMedGoogle Scholar
  53. 53.
    Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499–1504.PubMedGoogle Scholar
  54. 54.
    Coffey M, Reidy A, Wormald R, et al. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol ;77:17–21.PubMedGoogle Scholar
  55. 55.
    Bonomi L, Marchini G, Marraffa M, et al. Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study. Ophthalmology. 2000;107:998–1003.PubMedGoogle Scholar
  56. 56.
    Congdon N, Wang F, Tielsch JM. Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv Ophthalmol. 1992;36:411–423.PubMedGoogle Scholar
  57. 57.
    Erie JC, Hodge DO, Gray DT. The incidence of primary angle-closure glaucoma in Olmstead County, Minnesota. Arch Ophthalmol. 1997;115:177–181.PubMedGoogle Scholar
  58. 58.
    Foster PJ, Oen FT, Machin D, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol. 2000;118:1105–1111.PubMedGoogle Scholar
  59. 59.
    Congdon NG, Qi Y, Quigley HA, et al. Biometry and primary angle-closure glaucoma among Chinese, White and Black populations. Ophthalmology. 1997;104:1489–1495.PubMedGoogle Scholar
  60. 60.
    Aung T, Nolan WP, Machin D, et al. Anterior chamber depth and the risk of primary angle closure in 2 East Asian populations. Arch Ophthalmol. 2005;123:527–532.PubMedGoogle Scholar
  61. 61.
    Stanley H. Biometry. In: Stanley H, ed. Angle closure glaucoma. Amsterdam: Kugler & Ghedini; 1990.Google Scholar
  62. 62.
    Congdon NG, Youlin Q, Quigley H, et al. Biometry and primary angle-closure glaucoma among Chinese, white, and black populations. Ophthalmology. 1997;104:1489–1495.PubMedGoogle Scholar
  63. 63.
    Marchini G, Pagliarusco A, Toscano A, Tosi R, Brunelli C, Bonomi L. Ultrasound biomicroscopic and conventional ultrasonographic study of ocular dimensions in primary angle closure glaucoma. Ophthalmology. 1998;105:2091–2098.PubMedGoogle Scholar
  64. 64.
    Quigley HA, Silver DM, Friedman DS, et al. Iris cross-sectional area decreases with pupil dilation and its dynamic behavior is a risk factor in angle closure. J Glaucoma. 2009;18:173–183.PubMedGoogle Scholar
  65. 65.
    Fontana SC, Brubaker RF. Volume and depth of the anterior chamber in the normal aging human eye. Arch Ophthalmol. 1980;98:1803–1808.PubMedGoogle Scholar
  66. 66.
    Forbes M. Indentation gonioscopy and efficacy of iridectomy in angle-closure glaucoma. Trans Am Ophthalmol Soc. 1974;72:488–515.PubMedGoogle Scholar
  67. 67.
    Lam DS, Chua JK, Tham CC, Lai JS. Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle-closure glaucoma: a pilot study. Ophthalmology. 2002;109:64–70.PubMedGoogle Scholar
  68. 68.
    Lam DS, Lai JS, Tham CC, Chua JK, Poon AS. Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma: a prospective, randomized, controlled trial. Ophthalmology. 2002;109:1591–1596.PubMedGoogle Scholar
  69. 69.
    Lai JS, Tham CC, Chua JK, et al. To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure: mid-term results. Eye. 2006;20:309–314.PubMedGoogle Scholar
  70. 70.
    Lai JS, Tham CC, Chua JK, et al. To compare argon laser peripheral iridoplasty (ALPI) against systemic medications in treatment of acute primary angle-closure: mid-term results. Eye 2006;20:309–314.PubMedGoogle Scholar
  71. 71.
    Quaranta L, Bettelli S, et al. Argon laser iridoplasty as primary treatment for acute angle closure glaucoma: a prospective clinical study. Acta Ophthalmol Scand Suppl. 2002;236:16–17.PubMedGoogle Scholar
  72. 72.
    Aung T, Tow SL, Yap EY, et al. Trabeculectomy for acute primary angle closure. Ophthalmology. 2000;107:1298–1302.PubMedGoogle Scholar
  73. 73.
    Alsbirk PH. Anatomical risk factors in primary angle-closure glaucoma. A ten-year follow-up survey based on limbal and axial anterior chamber depths in a high risk population. Int Ophthalmol. 1992;16:265–272.PubMedGoogle Scholar
  74. 74.
    Wilensky JT, Kaufman PI, Frohlichstein D, et al. Follow-up angle-closure glaucoma suspects. Am J Ophthalmol 1993;115:338–346.PubMedGoogle Scholar
  75. 75.
    Ritch R, Stegman Z, Liebmann J. Mapstone’s hypothesis confirmed. Br J Ophthalmol. 1995;79:300.PubMedGoogle Scholar
  76. 76.
    Gazzard G, Foster PJ, Friedman DS, Khaw PT, Seah SK. Light to dark physiological variation in irido-trabecular angle width [videotape]. Br J Ophthalmol 2004;88:1357–1482.Google Scholar
  77. 77.
    Lim LS, Husain R, Gazzard G, Seah SK, Aung T. Cataract progression after prophylactic laser peripheral iridotomy: potential implications for the prevention of glaucoma blindness. Ophthalmology. 2005;112:1355–1359.PubMedGoogle Scholar
  78. 78.
    Robin AL, Pollack IP. A comparison of neodymium:YAG and argon laser iridotomies. Ophthalmology. 1984;91:1011–1016.PubMedGoogle Scholar
  79. 79.
    Schwartz GF, Steinmann WC, Spaeth GL, Wilson RP. Surgical and medical management of patients with narrow anterior chamber angles: comparative results. Ophthalmic Surg. 1992;23:108–112.PubMedGoogle Scholar
  80. 80.
    Friedman DS, Thomas R, Alsbirk PH, Gazzard G. Detection of primary angle closure glaucoma. In: Weinreb RN, Friedman DS, eds. Angle closure and angle closure glaucoma. The Hague, The Netherlands: Kuegler; 2006:55–63.Google Scholar
  81. 81.
    Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention and treatment. Surv Ophthalmol. 2009;54:211–225.PubMedGoogle Scholar
  82. 82.
    Nelson L, Maumenee IH. Ectopia lentis. Surv Ophthalmol. 1982;27:143–157.PubMedGoogle Scholar
  83. 83.
    Nemet AY, Assia EI, Apple DJ, Barequet IS. Current concepts of ocular manifestations in Marfan syndrome. Surv Ophthalmol. 2006;51:561–575.PubMedGoogle Scholar
  84. 84.
    Lovisolo CF, Reinstein DZ. Phakic intraocular lenses. Surv Ophthalmol. 2005;50:549–587.PubMedGoogle Scholar
  85. 85.
    von Graefe A. Beitrage zur Palhologie und Therapie des Glaukoms. Arch Ophthalmol 1869;15:108.Google Scholar
  86. 86.
    Klein R. Prevention of visual loss from diabetic retinopathy. Surv Ophthalmol. 2002;47:S246-S252.PubMedGoogle Scholar
  87. 87.
    Gunther JB, Altaweel MM. Bevacizumab (Avastin) for the treatment of. Surv Ophthalmol. 2009;54:372–400.PubMedGoogle Scholar
  88. 88.
    Yanoff M. Iridocorneal endothelial syndrome: unification of a disease spectrum. Surv Ophthalmol. 1979;24:1–20.PubMedGoogle Scholar
  89. 89.
    Hemady RK, Patel A, Blum S, Nirankari VS. Bilateral iridocorneal endothelial syndrome case report and review of the literature. Cornea. 1994;13:368–372.PubMedGoogle Scholar
  90. 90.
    Vargas LG, Vroman DT, Soloman KD, Holzer MP, et al. Epithelial downgrowth after clear cornea phacoemulsification. Ophthalmology 2002;12:2331–2335.Google Scholar
  91. 91.
    Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol 2005;50:351–363PubMedGoogle Scholar
  92. 92.
    Mendelsohn AD, Jampol LM, Schoch D. Secondary angle-closure after central retinal vein occlusion. Am J Ophthalmol. 1985;100:581–585.PubMedGoogle Scholar
  93. 93.
    Sodhi A, Leung L, Do DV, Gower EW, Schein OD, Handa JT. Recent trends in the Management of Rhegmatogenous Retinal Detachment. Surv Ophthalmol 2008;53:50–67PubMedGoogle Scholar
  94. 94.
    Levy J, Yagev R, Petrova A, Lifshiz T. Topiramate-induced bilateral angle-closure glaucoma. Can J Ophthalmol. 2006;41:221–225.PubMedGoogle Scholar
  95. 95.
    Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol 2007;125(1):30–37.PubMedGoogle Scholar

Bibliography

  1. Banta JT, Hoffman K, Budenz DL, et al. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol 2001;132(1):112–114.PubMedGoogle Scholar
  2. Beasley FJ. Transient myopia and retinal edema during hydrochlorothiazide (hydrodiuril) therapy. Arch Ophthalmol 1961;65:212–213.PubMedGoogle Scholar
  3. Beasley FJ. Transient myopia and retinal edema during ethoxzolamide (cardrase) therapy. Arch Ophthalmol 1962;68:490–491.PubMedGoogle Scholar
  4. Bovino JA, Marcus DF. The mechanism of transient myopia induced by sulfonamide therapy. Am J Ophthalmol 1982;94(1):99–102.PubMedGoogle Scholar
  5. Chen TC, Chao CW, Sorkin JA. Topiramate induced myopic shift and angle closure glaucoma. Br J Ophthalmol 2003;87(5):648–649.PubMedGoogle Scholar
  6. Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol 2004;137(1):193–195.PubMedGoogle Scholar
  7. Fan JT, Johnson DH, Burk RR. Transient myopia, angle-closure glaucoma, and choroidal detachment after oral acetazolamide. Am J Ophthalmol 1993;115(6):813–814.PubMedGoogle Scholar
  8. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology 2004;111(1):109–111.PubMedGoogle Scholar
  9. Garland MA, Sholk A, Guenter KE. Acetazolamide-induced myopia. Am J Obstet Gynecol 1962;84:69–71.PubMedGoogle Scholar
  10. Geanon JD, Perkins TW. Bilateral acute angle-closure glaucoma associated with drug sensitivity to hydrochlorothiazide. Arch Ophthalmol 1995;113(10):1231–1232.PubMedGoogle Scholar
  11. Grinbaum A, Ashkenazi I, Gutman I, et al. Suggested mechanism for acute transient myopia after sulfonamide treatment. Ann Ophthalmol 1993;25(6):224–226.PubMedGoogle Scholar
  12. Gubbay SS. The occurrence of drug-induced myopia as a transient side effect of topiramate. Epilepsia 1998;39(4):451.PubMedGoogle Scholar
  13. Ikeda N, Ikeda T, Nagata M, et al. Pathogenesis of transient high myopia after blunt eye trauma. Ophthalmology 2002;109(3):501–507.PubMedGoogle Scholar
  14. Ikeda N, Ikeda T, Nagata M, et al. Ciliochoroidal effusion syndrome induced by sulfa derivatives. Arch Ophthalmol 2002;120(12):1775.PubMedGoogle Scholar
  15. Kaniecki R. Neuromodulators for migraine prevention. Headache 2008;48(4):586–600.PubMedGoogle Scholar
  16. Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol 2007;18(2):129–133.PubMedGoogle Scholar
  17. Liebmann JM, Weinreb RN, Ritch R. Angle-closure glaucoma associated with occult annular ciliary body detachment. Arch Ophthalmol 1998;116(6):731–735.PubMedGoogle Scholar
  18. Medeiros FA, Zhang XY, Bernd AS, Weinreb RN. Angle-closure glaucoma associated with ciliary body detachment in patients using topiramate. Arch Ophthalmol 2003;121(2):282–285.PubMedGoogle Scholar
  19. Parikh R, Parikh S, Das S, et al. Choroidal drainage in the management of acute angle closure after topiramate toxicity. J Glaucoma 2007;16(8):691–693.PubMedGoogle Scholar
  20. Postel EA, Assalian A, Epstein DL. Drug-induced transient myopia and angle-closure glaucoma associated with supraciliary choroidal effusion. Am J Ophthalmol 1996;122(1):110–112.PubMedGoogle Scholar
  21. Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol 2001;119(11):1721–1723.PubMedGoogle Scholar
  22. Rhee DJ, Ramos-Esteban JC, Nipper KS. Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol. Am J Ophthalmol 2006;141(6):1133–1134.PubMedGoogle Scholar
  23. Ritch R, Chang BM, Liebmann JM. Angle closure in younger patients. Ophthalmology 2003;110(10):1880–1889.PubMedGoogle Scholar
  24. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusion and secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol 2001;119(8):1210–1211.PubMedGoogle Scholar
  25. Thambi L, Kapcala LP, Chambers W, et al. Topiramate-associated secondary angle–closure glaucoma: a case series. Arch Ophthalmol 2002;120(8):1108.PubMedGoogle Scholar
  26. Viet Tran H, Ravinet E, Schnyder C, et al. Blood-brain barrier disruption associated with topiramate-induced angle-closure glaucoma of acute onset. Klin Monatsbl Augenheilkd 2006;223(5):425–457.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Marshall N. Cyrlin
    • 1
    • 2
    • 3
  1. 1.Oakland University William Beaumont School of MedicineRochesterUSA
  2. 2.Glaucoma Services, William Beaumont Eye InstituteRoyal OakUSA
  3. 3.SouthfieldUSA

Personalised recommendations